Skip to main content

Testing version — LOERadar is in active testing. Features and data may change.

Hub News Changes Search

LOERadar

FDA drug patent and exclusivity intelligence, assembled from public records.

Sponsored by

About Terms of Service Privacy Policy Log in

Attorney Advertising

© 2026 LOERadar · An informational research tool drawn from public records; it is not a law firm, does not provide legal advice, and its use does not create an attorney-client relationship.

TIMENTIN (CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM) | LOERadar

Viewing data from:

TIMENTIN

ANDA

CLAVULANATE POTASSIUM; TICARCILLIN DISODIUM | A062691 | GLAXOSMITHKLINE INTELLECTUAL PROPERTY NO 2 LTD ENGLAND

1 strength0 unique patents0 unique exclusivities

Products (1)

#001 — EQ 100MG BASE/VIAL;EQ 3GM BASE/VIAL

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Dec 19, 1986

No patent or exclusivity listings for this strength.